Exploring Gene Therapy: The Next Generation of Colorectal Cancer Treatment

References

1. PalmerD.H. ChenM.J. KerrD.J. Gene therapy for colorectal cancer.Br. Med. Bull.200264120122510.1093/bmb/64.1.201 12421734
   [Google Scholar]
2. HasbullahH.H. MusaM. Gene therapy targeting p53 and KRAS for colorectal cancer treatment: A myth or the way forward?Int. J. Mol. Sci.202122211194110.3390/ijms222111941 34769370
   [Google Scholar]
3. KamraniA NasiriH HassanzadehA Ahmadian HerisJ MohammadinasabR SadeghvandS. New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses.Cell Commun Signal20245610.1186/s12964‑023‑01430‑8
   [Google Scholar]
4. YuY. Nangia-MakkerP. MajumdarA.P.N. Overcoming drug resistance in colorectal cancer by microRNAs. In: MicroRNA Targeted Cancer Therapy.ChamSpringer International Publishing201413915510.1007/978‑3‑319‑05134‑5_8
   [Google Scholar]
5. ZhianiM. MousaviM.A. RostamizadehK. Apoptosis induction by siRNA targeting integrin-β1 and regorafenib/DDAB-mPEG-PCL hybrid nanoparticles in regorafenib-resistant colon cancer cells.Am. J. Cancer Res.202111411701184 33948352
   [Google Scholar]
6. WangJ ChenX XieC SunM HuC ZhangZ. MicroRNA miR-29a inhibits colon cancer progression by downregulating B7-H3 expression: Potential molecular targets for colon cancer therapy.Mol Biotechnol20216398496110.1007/s12033‑021‑00348‑1
   [Google Scholar]
7. UedaN. CahenM. DangerY. MoreauxJ. SiracC. CognéM. Immunotherapy perspectives in the new era of B-cell editing.Blood Adv.2021561770177910.1182/bloodadvances.2020003792 33755093
   [Google Scholar]
8. MokhtariM. KhoshbakhtS. AkbariM.E. MoravvejiS.S. BMC3PM: Bioinformatics multidrug combination protocol for personalized precision medicine and its application in cancer treatment.BMC Med. Genomics202316132810.1186/s12920‑023‑01745‑y
   [Google Scholar]